Ivabradine in heart failure—no paradigm SHIFT…yet

This publication has 18 references indexed in Scilit:

• Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial
  The Lancet, 2010
• The Role of the Funny Current in Pacemaker Activity
  Circulation Research, 2010
• Fallacies in clinical cardiovascular trials
  Heart, 2009
• Chronic heart rate reduction by ivabradine prevents endothelial dysfunction in dyslipidaemic mice
  British Journal of Pharmacology, 2008
• Heart Rate Reduction by Ivabradine Reduces Oxidative Stress, Improves Endothelial Function, and Prevents Atherosclerosis in Apolipoprotein E–Deficient Mice
  Circulation, 2008
• Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction
  European Heart Journal, 2008
• Direct evidence for calcium conductance of hyperpolarization-activated cyclic nucleotide-gated channels and human native If at physiological calcium concentrations
  Cardiovascular Research, 2008
• The Properties of the Pacemaker Current IFin Human Ventricular Myocytes are Modulated by Cardiac Disease
  Journal of Molecular and Cellular Cardiology, 2001
• The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
  The Lancet, 1999
• The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
  New England Journal of Medicine, 1996